![O-(N-Acetyl-α-neuraminosyl)-(2→6)-O-[O-(N-acetyl-α-neuraminosyl)-(2→3)-β-D-galactopyranosyl-(1→3)]…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F383964-o-n-acetyl-a-neuraminosyl-2-6-o-o-n-acetyl-a-neuraminosyl-2-3-b-d-galactopyranosyl-1-3-2-acetylamino-2-deoxy-d-galactose.webp&w=3840&q=75)
CAS 71764-07-3: O-(N-Acetil-α-neuraminosil)-(2→6)-O-[O-(N-acetil-α-neuraminosil)-(2→3)-β-D-galattopiranosil-(1→3)]-2-(acetilamino)-2-desossi-D-galattosio
Descrizione:
La sostanza chimica nota come O-(N-Acetil-α-neuraminosil)-(2→6)-O-[O-(N-acetil-α-neuraminosil)-(2→3)-β-D-galattopiranosil-(1→3)]-2-(acetilamino)-2-desossi-D-galattosio, con il numero CAS 71764-07-3, è un composto glicosilato complesso. Presenta più unità di zucchero, tra cui acido N-acetilneuraminico (un acido sialico) e galattosio, legate tramite specifici legami glicosidici. Questa struttura suggerisce che potrebbe svolgere un ruolo nei processi biologici come il riconoscimento cellulare, la segnalazione e l'adesione, in particolare nel contesto delle interazioni cellulari e delle risposte immunitarie. La presenza di gruppi acetilamino indica una potenziale solubilità nei fluidi biologici e potrebbe influenzare la sua attività biologica. Inoltre, la stereochimica delle unità di zucchero e i legami specifici contribuiscono alle sue proprietà funzionali. Composti di questo tipo sono spesso studiati per la loro rilevanza nella glicobiologia e per le potenziali applicazioni in terapia, diagnostica e sviluppo di vaccini. Comprendere le caratteristiche di questo composto può fornire informazioni sulla sua importanza biologica e sui possibili usi in medicina e biotecnologia.
Formula:C36H59N3O27
InChI:InChI=1S/C36H59N3O27/c1-11(44)37-14(6-40)28(25(54)19(51)10-61-35(33(57)58)4-15(47)21(38-12(2)45)29(64-35)23(52)17(49)7-41)63-32-27(56)31(26(55)20(9-43)62-32)66-36(34(59)60)5-16(48)22(39-13(3)46)30(65-36)24(53)18(50)8-42/h6,14-32,41-43,47-56H,4-5,7-10H2,1-3H3,(H,37,44)(H,38,45)(H,39,46)(H,57,58)(H,59,60)/t14-,15-,16-,17+,18+,19+,20+,21+,22+,23+,24+,25-,26-,27+,28+,29+,30+,31-,32-,35+,36-/m0/s1
InChI key:InChIKey=SKJCZIMWAATHMG-CZYIXMLQSA-N
SMILES:O([C@@]1(C(O)=O)O[C@@]([C@@H]([C@@H](CO)O)O)([C@H](NC(C)=O)[C@@H](O)C1)[H])[C@@H]2[C@@H](O)[C@H](O[C@H]([C@@H](NC(C)=O)C=O)[C@H]([C@@H](CO[C@@]3(C(O)=O)O[C@@]([C@@H]([C@@H](CO)O)O)([C@H](NC(C)=O)[C@@H](O)C3)[H])O)O)O[C@H](CO)[C@@H]2O
Sinonimi:- (2S,4S,5R,6R)-5-acetamido-2-[(2R,3R,4S,5S,6R)-2-[(2R,3R,4S,5R)-2-acetamido-6-[(2R,4S,5R,6R)-5-acetamido-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-4,5-dihydroxy-1-oxo-hexan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
- <span class="text-smallcaps">D</smallcap>-Galactose, O-(N-acetyl-α-neuraminosyl)-(2→6)-O-[O-(N-acetyl-α-neuraminosyl)-(2→3)-β-<smallcap>D</span>-galactopyranosyl-(1→3)]-2-(acetylamino)-2-deoxy-
- Disialosyl galactosyl globoside
- O-(N-Acetyl-α-neuraminosyl)-(2→6)-O-[O-(N-acetyl-α-neuraminosyl)-(2→3)-β-<span class="text-smallcaps">D</smallcap>-galactopyranosyl-(1→3)]-2-(acetylamino)-2-deoxy-<smallcap>D</span>-galactose
- O-(N-Acetyl-α-neuraminosyl)-(2→6)-O-[O-(N-acetyl-α-neuraminosyl)-(2→3)-β-D-galactopyranosyl-(1→3)]-2-(acetylamino)-2-deoxy-D-galactose
- D-Galactose, O-(N-acetyl-α-neuraminosyl)-(2→6)-O-[O-(N-acetyl-α-neuraminosyl)-(2→3)-β-D-galactopyranosyl-(1→3)]-2-(acetylamino)-2-deoxy-
Ordinare per
1 prodotti.
Disialyl-TF
CAS:Disialyl-TF is a monoclonal antibody that binds to the CD33 antigen on the surface of all types of cancer cells, including breast cancer cells. Disialyl-TF has been shown to reduce the growth and spread of prostate cancer cells in mice, reducing tumor size and weight. Disialyl-TF is also active against infectious diseases such as HIV, which may be due to its ability to inhibit the expression of glycan receptors. The mechanism by which it works is not yet known. Disialyl-TF has been shown to bind with high affinity to erythrocytes bearing A or B blood group antigens, making it an excellent diagnostic tool for detecting these antigens in patients with acute myeloid leukemia or other cancers.Formula:C36H59N3O27Purezza:Min. 95%Peso molecolare:965.86 g/mol